Development of a lytic peptide derived from BH3-only proteins

Despite great advances in cancer therapy, drug resistance is a difficult hurdle to overcome that requires development of anticancer agents with novel and effective modes of action. In a number of studies, lytic peptides have shown remarkable ability to eliminate cancer cells through a different way...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Q, Zhao, H, Jiang, Y, Wu, M, Tian, Y, Wang, D, Lao, Y, Xu, N, Li, Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979451/
https://www.ncbi.nlm.nih.gov/pubmed/27551502
http://dx.doi.org/10.1038/cddiscovery.2016.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979451/
https://www.ncbi.nlm.nih.gov/pubmed/27551502
http://dx.doi.org/10.1038/cddiscovery.2016.8

Ejemplares similares